Published on in Vol 11, No 7 (2022): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/36780, first published .
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

Lakshmanan Krishnamurti   1 , MD ;   Staci D Arnold   1 , MD, MPH, MBA ;   Ann Haight   1 , MD ;   Allistair Abraham   2 , MD ;   Gregory MT Guilcher   3 , MD ;   Tami John   4 , MD ;   Nitya Bakshi   1 , MBBS, MS ;   Shalini Shenoy   5 , MD ;   Karen Syrjala   6 , PhD ;   Paul L Martin   7 , MD, PhD ;   Sonali Chaudhury   8 , MD ;   Gretchen Eames   9 , MD ;   Olusola Festus Olowoselu   10 , MD ;   Matthew Hsieh   11 , MD ;   Josu De La Fuente   12 , PhD ;   Kimberly A Kasow   13 , DO ;   Elizabeth Stenger   1 , MD, MSc ;   Anne Mertens   1 , MS, PhD ;   Fuad El-Rassi   14 , MD ;   Peter Lane   1 , MD ;   Bronwen E Shaw   15 , MD, PhD ;   Lillian Meacham   1 , MD ;   David Archer   1 , PhD

1 Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States

2 Pediatric Hematology/Oncology/Blood and Marrow Transplantation, Children's National Health System, Washington, DC, United States

3 Section of Pediatric Oncology and Blood and Marrow Transplant, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada

4 Bone Marrow Transplant / Stem Cell Transplant Program, Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States

5 Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Washington University in St. Louis, St. Louis, MO, United States

6 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States

7 Pediatric Transplant and Cellular Therapy, Duke University School of Medicine, Durham, NC, United States

8 Division of Pediatric Hematology Oncology/Bone Marrow Transplantation, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, United States

9 Division of Pediatric Hematology/Oncology/BMT, Cook Children's Medical Center, Fortworth, TX, United States

10 Department of Medicine and Hematology, Lagos University Teaching Hospital, Lagos, Nigeria

11 National Institutes of Health Clinical Center, National Heart, Lung, and Blood Institute, Bethesda, MD, United States

12 Division of Pediatric Hematology/Oncology/BMT, Imperial College London Faculty of Medicine, St. Mary's Hospital, London, United Kingdom

13 Division of Pediatric Hematology Oncology, University of North Carolina, Chapel Hill, NC, United States

14 Department of Hematology, Emory University School of Medicine, Atlanta, GA, United States

15 Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States

Corresponding Author:

  • Lakshmanan Krishnamurti, MD
  • Aflac Cancer and Blood Disorders Center
  • Children's Healthcare of Atlanta
  • Emory University School of Medicine
  • 1405 Clifton Rd NE
  • Atlanta, GA, 30322-1060
  • United States
  • Phone: 1 412-612-4761
  • Email: lkrishn@emory.edu